NUWE - Nuwellis, Inc. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

NUWE

NUWELLIS, INC.

NASDAQ

$1.16

▲ UP 3.57% (0.04)

KEY STATISTICS

Market Cap$106.95 K

52w High$187.60

52w Low$1.11

Dividend Yield—

Frequency—

P/E-0.51

Volume226.04K

Shares Out.92.20K

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Michael McCormick

COMPENSATION 2026

Salary$341,396

Stock Awards$0

Incentive Plan Pay$0

All Other Comp.$8,904

Total$375,197

ABOUT

SECTOR

Healthcare

WENT PUBLIC

February 16, 2012

METHOD OF GOING PUBLIC

SPAC

FULL TIME EMPLOYEES

UPCOMING EARNINGS

DateNov 11, 2026

DayWednesday

Rev. Est.$2.50M

NOV

WED

SPLIT RECORD

DATE	TYPE	RATIO
2026-06-26	Reverse	1:35
2025-07-07	Reverse	1:42
2024-06-28	Reverse	1:35
2022-12-12	Reverse	1:100
2020-10-19	Reverse	1:30
2019-01-03	Reverse	1:14
2017-10-13	Reverse	1:20
2017-01-19	Reverse	1:30
2017-01-13	Reverse	1:30

PRICE

$1.16 ▲ UP 3.57% (+$0.04)

OVERLAYS

About Nuwellis, Inc.

https://www.nuwellis.com ↗

Nuwellis, Inc. develops and sells ultrafiltration medical devices like the Aquadex systems for treating fluid overload, serving hospitals worldwide through direct sales and distributors.

INDUSTRY

Medical - Devices

A PRODUCT NUWELLIS, INC. IS KNOWN FOR

Aquadex SmartFlow System

The Aquadex SmartFlow System is a medical device that offers ultrafiltration therapy to remove excess fluid in patients unresponsive to other treatments like diuretics.